TocilizumabV1, France, Analysis, bibRecord, 000630

Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis

Identifieur interne : 000630 ( France/Analysis ); précédent : 000629; suivant : 000631

Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis

Auteurs : Camille Cohen [France] ; Arsene Mekinian [France] ; Nathalie Saidenberg-Kermanac'H [France] ; Jerôme Stirnemann [France] ; Pierre Fenaux [France] ; Romain Gherardi [France] ; Olivier Fain [France]

Source :

Annals of the Rheumatic Diseases [ 0003-4967 ] ; 2012-04.

RBID : ISTEX:A1998B0CCFC3BFC98C157B3A0077F20917365B45

Descripteurs français

KwdFr :
- Adulte d'âge moyen, Anticorps monoclonaux d'origine murine (usage thérapeutique), Anticorps monoclonaux humanisés (usage thérapeutique), Cryoglobulinémie (traitement médicamenteux), Facteurs immunologiques (usage thérapeutique), Humains, Mâle, Rituximab, Résistance aux substances, Vascularite (traitement médicamenteux).
MESH :
- traitement médicamenteux : Cryoglobulinémie, Vascularite.
- usage thérapeutique : Anticorps monoclonaux d'origine murine, Anticorps monoclonaux humanisés, Facteurs immunologiques.
Pascal (Inist)
- Cryoglobulinémie, Immunodépresseur, Immunomodulateur, Rhumatologie, Tocilizumab, Vascularite.
MESH :
- Adulte d'âge moyen, Humains, Mâle, Rituximab, Résistance aux substances.

English descriptors

KwdEn :
- Antibodies, Monoclonal, Humanized (therapeutic use), Antibodies, Monoclonal, Murine-Derived (therapeutic use), Cryoglobulinemia, Cryoglobulinemia (drug therapy), Drug Resistance, Humans, Immunologic Factors (therapeutic use), Immunomodulator, Immunosuppressive agent, Male, Middle Aged, Rheumatology, Rituximab, Tocilizumab, Vasculitis, Vasculitis (drug therapy).
MESH :
- chemical , therapeutic use : Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Murine-Derived, Immunologic Factors.
- drug therapy : Cryoglobulinemia, Vasculitis.
Teeft :
- Birmingham vasculitis activity score, Cryoglobulinemia, Cryoglobulinemia vasculitis, Drug Resistance, Humans, Jean verdier, Male, Middle Aged, Muscle biopsy, Muscular pain, Myocyte, Myocyte atrophy, Myocyte involvement, Rankin score, Rheum, Rheumatoid arthritis, Rituximab, Tocilizumab, Universit, Vasculitis.

Url:

https://api.istex.fr/ark:/67375/NVC-580LJK6B-9/fulltext.pdf

DOI: 10.1136/annrheumdis-2011-200501

Affiliations:

Links to Exploration step

ISTEX:A1998B0CCFC3BFC98C157B3A0077F20917365B45

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis</title>
<author><name sortKey="Cohen, Camille" sort="Cohen, Camille" uniqKey="Cohen C" first="Camille" last="Cohen">Camille Cohen</name>
</author>
<author><name sortKey="Mekinian, Arsene" sort="Mekinian, Arsene" uniqKey="Mekinian A" first="Arsene" last="Mekinian">Arsene Mekinian</name>
</author>
<author><name sortKey="Saidenberg Kermanac H, Nathalie" sort="Saidenberg Kermanac H, Nathalie" uniqKey="Saidenberg Kermanac H N" first="Nathalie" last="Saidenberg-Kermanac'H">Nathalie Saidenberg-Kermanac'H</name>
</author>
<author><name sortKey="Stirnemann, Jerome" sort="Stirnemann, Jerome" uniqKey="Stirnemann J" first="Jerôme" last="Stirnemann">Jerôme Stirnemann</name>
</author>
<author><name sortKey="Fenaux, Pierre" sort="Fenaux, Pierre" uniqKey="Fenaux P" first="Pierre" last="Fenaux">Pierre Fenaux</name>
</author>
<author><name sortKey="Gherardi, Romain" sort="Gherardi, Romain" uniqKey="Gherardi R" first="Romain" last="Gherardi">Romain Gherardi</name>
</author>
<author><name sortKey="Fain, Olivier" sort="Fain, Olivier" uniqKey="Fain O" first="Olivier" last="Fain">Olivier Fain</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A1998B0CCFC3BFC98C157B3A0077F20917365B45</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1136/annrheumdis-2011-200501</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-580LJK6B-9/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000400</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000400</idno>
<idno type="wicri:Area/Istex/Curation">000400</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E84</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E84</idno>
<idno type="wicri:doubleKey">0003-4967:2012:Cohen C:efficacy:of:tocilizumab</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:22121135</idno>
<idno type="wicri:Area/PubMed/Corpus">001938</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001938</idno>
<idno type="wicri:Area/PubMed/Curation">001938</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001938</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001773</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001773</idno>
<idno type="wicri:Area/Ncbi/Merge">000506</idno>
<idno type="wicri:Area/Ncbi/Curation">000506</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000506</idno>
<idno type="wicri:Area/Main/Merge">003595</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:12-0272419</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000103</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000161</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000107</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000107</idno>
<idno type="wicri:doubleKey">0003-4967:2012:Cohen C:efficacy:of:tocilizumab</idno>
<idno type="wicri:Area/Main/Merge">003873</idno>
<idno type="wicri:Area/Main/Curation">003569</idno>
<idno type="wicri:Area/Main/Exploration">003569</idno>
<idno type="wicri:Area/France/Extraction">000630</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis</title>
<author><name sortKey="Cohen, Camille" sort="Cohen, Camille" uniqKey="Cohen C" first="Camille" last="Cohen">Camille Cohen</name>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de médecine interne, Université Paris 13, AP-HP, Hôpital Jean Verdier, 93140, Bondy</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Bondy</settlement>
</placeName>
<orgName type="university">Université Paris 13</orgName>
</affiliation>
</author>
<author><name sortKey="Mekinian, Arsene" sort="Mekinian, Arsene" uniqKey="Mekinian A" first="Arsene" last="Mekinian">Arsene Mekinian</name>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de médecine interne, Université Paris 13, AP-HP, Hôpital Jean Verdier, 93140, Bondy</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Bondy</settlement>
</placeName>
<orgName type="university">Université Paris 13</orgName>
</affiliation>
</author>
<author><name sortKey="Saidenberg Kermanac H, Nathalie" sort="Saidenberg Kermanac H, Nathalie" uniqKey="Saidenberg Kermanac H N" first="Nathalie" last="Saidenberg-Kermanac'H">Nathalie Saidenberg-Kermanac'H</name>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de rhumatologie, Université Paris 13, AP-HP, Hôpital Avicenne, 93000, Bobigny</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Bobigny</settlement>
</placeName>
<orgName type="university">Université Paris 13</orgName>
</affiliation>
</author>
<author><name sortKey="Stirnemann, Jerome" sort="Stirnemann, Jerome" uniqKey="Stirnemann J" first="Jerôme" last="Stirnemann">Jerôme Stirnemann</name>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de médecine interne, Université Paris 13, AP-HP, Hôpital Jean Verdier, 93140, Bondy</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Bondy</settlement>
</placeName>
<orgName type="university">Université Paris 13</orgName>
</affiliation>
</author>
<author><name sortKey="Fenaux, Pierre" sort="Fenaux, Pierre" uniqKey="Fenaux P" first="Pierre" last="Fenaux">Pierre Fenaux</name>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Service d’hématologie, Université Paris 13, AP-HP, Hôpital Avicenne, 93000, Bobigny</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Bobigny</settlement>
</placeName>
<orgName type="university">Université Paris 13</orgName>
</affiliation>
</author>
<author><name sortKey="Gherardi, Romain" sort="Gherardi, Romain" uniqKey="Gherardi R" first="Romain" last="Gherardi">Romain Gherardi</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de pathologie, Université Paris 12, AP-HP, Hopital Henri Mondor, 94000, Créteil</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Créteil</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fain, Olivier" sort="Fain, Olivier" uniqKey="Fain O" first="Olivier" last="Fain">Olivier Fain</name>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de médecine interne, Université Paris 13, AP-HP, Hôpital Jean Verdier, 93140, Bondy</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Bondy</settlement>
</placeName>
<orgName type="university">Université Paris 13</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint><publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2012-04">2012-04</date>
<biblScope unit="volume">71</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="628">628</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal, Humanized (therapeutic use)</term>
<term>Antibodies, Monoclonal, Murine-Derived (therapeutic use)</term>
<term>Cryoglobulinemia</term>
<term>Cryoglobulinemia (drug therapy)</term>
<term>Drug Resistance</term>
<term>Humans</term>
<term>Immunologic Factors (therapeutic use)</term>
<term>Immunomodulator</term>
<term>Immunosuppressive agent</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Rheumatology</term>
<term>Rituximab</term>
<term>Tocilizumab</term>
<term>Vasculitis</term>
<term>Vasculitis (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Anticorps monoclonaux d'origine murine (usage thérapeutique)</term>
<term>Anticorps monoclonaux humanisés (usage thérapeutique)</term>
<term>Cryoglobulinémie (traitement médicamenteux)</term>
<term>Facteurs immunologiques (usage thérapeutique)</term>
<term>Humains</term>
<term>Mâle</term>
<term>Rituximab</term>
<term>Résistance aux substances</term>
<term>Vascularite (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
<term>Antibodies, Monoclonal, Murine-Derived</term>
<term>Immunologic Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cryoglobulinemia</term>
<term>Vasculitis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Cryoglobulinémie</term>
<term>Vascularite</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux d'origine murine</term>
<term>Anticorps monoclonaux humanisés</term>
<term>Facteurs immunologiques</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Cryoglobulinémie</term>
<term>Immunodépresseur</term>
<term>Immunomodulateur</term>
<term>Rhumatologie</term>
<term>Tocilizumab</term>
<term>Vascularite</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Birmingham vasculitis activity score</term>
<term>Cryoglobulinemia</term>
<term>Cryoglobulinemia vasculitis</term>
<term>Drug Resistance</term>
<term>Humans</term>
<term>Jean verdier</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Muscle biopsy</term>
<term>Muscular pain</term>
<term>Myocyte</term>
<term>Myocyte atrophy</term>
<term>Myocyte involvement</term>
<term>Rankin score</term>
<term>Rheum</term>
<term>Rheumatoid arthritis</term>
<term>Rituximab</term>
<term>Tocilizumab</term>
<term>Universit</term>
<term>Vasculitis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Humains</term>
<term>Mâle</term>
<term>Rituximab</term>
<term>Résistance aux substances</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Bobigny</li>
<li>Bondy</li>
<li>Créteil</li>
</settlement>
<orgName><li>Université Paris 13</li>
</orgName>
</list>
<tree><country name="France"><region name="Île-de-France"><name sortKey="Cohen, Camille" sort="Cohen, Camille" uniqKey="Cohen C" first="Camille" last="Cohen">Camille Cohen</name>
</region>
<name sortKey="Fain, Olivier" sort="Fain, Olivier" uniqKey="Fain O" first="Olivier" last="Fain">Olivier Fain</name>
<name sortKey="Fenaux, Pierre" sort="Fenaux, Pierre" uniqKey="Fenaux P" first="Pierre" last="Fenaux">Pierre Fenaux</name>
<name sortKey="Gherardi, Romain" sort="Gherardi, Romain" uniqKey="Gherardi R" first="Romain" last="Gherardi">Romain Gherardi</name>
<name sortKey="Mekinian, Arsene" sort="Mekinian, Arsene" uniqKey="Mekinian A" first="Arsene" last="Mekinian">Arsene Mekinian</name>
<name sortKey="Saidenberg Kermanac H, Nathalie" sort="Saidenberg Kermanac H, Nathalie" uniqKey="Saidenberg Kermanac H N" first="Nathalie" last="Saidenberg-Kermanac'H">Nathalie Saidenberg-Kermanac'H</name>
<name sortKey="Stirnemann, Jerome" sort="Stirnemann, Jerome" uniqKey="Stirnemann J" first="Jerôme" last="Stirnemann">Jerôme Stirnemann</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000630 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000630 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:A1998B0CCFC3BFC98C157B3A0077F20917365B45
   |texte=   Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis
}}

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

Serveur d'exploration Tocilizumab

Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis

Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Serveur d'exploration Tocilizumab
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.